BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

469 related articles for article (PubMed ID: 16484002)

  • 21. The use of p63 as an effective immunomarker in the diagnosis of pulmonary squamous cell carcinomas on de-stained bronchial lavage cytological smears.
    Uke M; Rekhi B; Ajit D; Jambhekar NA
    Cytopathology; 2010 Feb; 21(1):56-63. PubMed ID: 19744186
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of p63 expression on survival in oral squamous cell carcinoma.
    Lo Muzio L; Campisi G; Farina A; Rubini C; Pastore L; Giannone N; Colella G; Leonardi R; Carinci F
    Cancer Invest; 2007 Sep; 25(6):464-9. PubMed ID: 17882659
    [TBL] [Abstract][Full Text] [Related]  

  • 23. p63 expression in breast cancer: a highly sensitive and specific marker of metaplastic carcinoma.
    Koker MM; Kleer CG
    Am J Surg Pathol; 2004 Nov; 28(11):1506-12. PubMed ID: 15489655
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The expression of p63 and cytokeratin 5 in mixed tumors of the canine mammary gland provides new insights into the histogenesis of these neoplasms.
    Ramalho LN; Ribeiro-Silva A; Cassali GD; Zucoloto S
    Vet Pathol; 2006 Jul; 43(4):424-9. PubMed ID: 16846983
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metaplastic breast carcinoma: clinical-pathologic characteristics and HER2/neu expression.
    Barnes PJ; Boutilier R; Chiasson D; Rayson D
    Breast Cancer Res Treat; 2005 May; 91(2):173-8. PubMed ID: 15868445
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunohistochemical staining for p63 is useful in the diagnosis of anal squamous cell carcinomas.
    Owens SR; Greenson JK
    Am J Surg Pathol; 2007 Feb; 31(2):285-90. PubMed ID: 17255774
    [TBL] [Abstract][Full Text] [Related]  

  • 27. p63: a novel myoepithelial cell marker in canine mammary tissues.
    Gama A; Alves A; Gartner F; Schmitt F
    Vet Pathol; 2003 Jul; 40(4):412-20. PubMed ID: 12824513
    [TBL] [Abstract][Full Text] [Related]  

  • 28. p63 immunostaining in destained bronchoscopic cytological specimens.
    Shtilbans V; Szporn AH; Wu M; Burstein DE
    Diagn Cytopathol; 2005 Apr; 32(4):198-203. PubMed ID: 15754365
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ubiquitous p63 expression in human esophageal squamous cell carcinoma.
    Hara T; Kijima H; Yamamoto S; Kenmochi T; Kise Y; Tanaka H; Chino O; Shimada H; Takazawa K; Tanaka M; Inokuchi S; Makuuchi H
    Int J Mol Med; 2004 Aug; 14(2):169-73. PubMed ID: 15254760
    [TBL] [Abstract][Full Text] [Related]  

  • 30. p63 correlates with both BRCA1 and cytokeratin 5 in invasive breast carcinomas: further evidence for the pathogenesis of the basal phenotype of breast cancer.
    Ribeiro-Silva A; Ramalho LN; Garcia SB; Brandão DF; Chahud F; Zucoloto S
    Histopathology; 2005 Nov; 47(5):458-66. PubMed ID: 16241993
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metaplastic breast carcinoma: pathology and clinical outcome.
    Bellino R; Arisio R; D'Addato F; Attini R; Durando A; Danese S; Bertone E; Grio R; Massobrio M
    Anticancer Res; 2003; 23(1B):669-73. PubMed ID: 12680165
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stromal keratin expression in phyllodes tumours of the breast: a comparison with other spindle cell breast lesions.
    Chia Y; Thike AA; Cheok PY; Yong-Zheng Chong L; Man-Kit Tse G; Tan PH
    J Clin Pathol; 2012 Apr; 65(4):339-47. PubMed ID: 22259180
    [TBL] [Abstract][Full Text] [Related]  

  • 33. E-cadherin loss and Delta Np73L expression in oral squamous cell carcinomas showing aggressive behavior.
    Foschini MP; Cocchi R; Morandi L; Marucci G; Pennesi MG; Righi A; Tosi AL; de Biase D; Pession A; Montebugnoli L
    Head Neck; 2008 Nov; 30(11):1475-82. PubMed ID: 18704970
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical, histopathologic, and immunohistochemical features of microglandular adenosis and transition into in situ and invasive carcinoma.
    Khalifeh IM; Albarracin C; Diaz LK; Symmans FW; Edgerton ME; Hwang RF; Sneige N
    Am J Surg Pathol; 2008 Apr; 32(4):544-52. PubMed ID: 18300793
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunohistochemical distinction of cutaneous spindle cell carcinoma.
    Morgan MB; Purohit C; Anglin TR
    Am J Dermatopathol; 2008 Jun; 30(3):228-32. PubMed ID: 18496422
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The pathology of low-grade adenosquamous carcinoma of the breast. An immunohistochemical study.
    Drudis T; Arroyo C; Van Hoeven K; Cordon-Cardo C; Rosen PP
    Pathol Annu; 1994; 29 ( Pt 2)():181-97. PubMed ID: 7936747
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metaplastic spindle cell breast tumors arising within papillomas, complex sclerosing lesions, and nipple adenomas.
    Gobbi H; Simpson JF; Jensen RA; Olson SJ; Page DL
    Mod Pathol; 2003 Sep; 16(9):893-901. PubMed ID: 13679453
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of p63 protein and mRNA in oral epithelial dysplasia.
    Chen YK; Hsue SS; Lin LM
    J Oral Pathol Med; 2005 Apr; 34(4):232-9. PubMed ID: 15752259
    [TBL] [Abstract][Full Text] [Related]  

  • 39. p63 Expression of clear myoepithelial cells in epithelial-myoepithelial carcinoma of the salivary gland: a useful marker for naked myoepithelial cells in cytology.
    Kawahara A; Harada H; Yokoyama T; Kage M
    Cancer; 2005 Aug; 105(4):240-5. PubMed ID: 15959915
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sarcomatoid squamous cell carcinoma of the penis: a clinical and pathological study of 5 cases.
    Lont AP; Gallee MP; Snijders P; Horenblas S
    J Urol; 2004 Sep; 172(3):932-5. PubMed ID: 15311001
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.